These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. What is the quality of reporting in weight loss intervention studies? A systematic review of randomized controlled trials. Thabane L; Chu R; Cuddy K; Douketis J Int J Obes (Lond); 2007 Oct; 31(10):1554-9. PubMed ID: 17452988 [TBL] [Abstract][Full Text] [Related]
23. Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement. Rikos D; Dardiotis E; Tsivgoulis G; Zintzaras E; Hadjigeorgiou GM Mult Scler Relat Disord; 2016 Sep; 9():135-9. PubMed ID: 27645361 [TBL] [Abstract][Full Text] [Related]
24. Randomised controlled trials and quality of journals. Weale AR; Lear PA Lancet; 2003 May; 361(9370):1749-50. PubMed ID: 12767778 [No Abstract] [Full Text] [Related]
25. CONSORT 2010 statement: extension to randomised crossover trials. Dwan K; Li T; Altman DG; Elbourne D BMJ; 2019 Jul; 366():l4378. PubMed ID: 31366597 [TBL] [Abstract][Full Text] [Related]
31. [Emphasizing of ethical criteria for medical scientific reporting and the Declaration of Helsinki]. Gebhardt DO Ned Tijdschr Geneeskd; 1999 Feb; 143(9):494-5. PubMed ID: 10221127 [No Abstract] [Full Text] [Related]
32. From quality of publication to quality of care: translating trials to practice. Dancey JE J Natl Cancer Inst; 2010 May; 102(10):670-1. PubMed ID: 20410467 [No Abstract] [Full Text] [Related]
33. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Dean ME; Coulter MK; Fisher P; Jobst K; Walach H Homeopathy; 2007 Jan; 96(1):42-5. PubMed ID: 17227747 [TBL] [Abstract][Full Text] [Related]
34. Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. Kober T; Trelle S; Engert A J Natl Cancer Inst; 2006 May; 98(9):620-5. PubMed ID: 16670387 [TBL] [Abstract][Full Text] [Related]
35. [The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials]. Moher D; Schulz KF; Altman DG; Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):658-61. PubMed ID: 16089150 [No Abstract] [Full Text] [Related]
36. The quality of safety reporting in trials is still suboptimal: survey of major general medical journals. Haidich AB; Birtsou C; Dardavessis T; Tirodimos I; Arvanitidou M J Clin Epidemiol; 2011 Feb; 64(2):124-35. PubMed ID: 21172601 [TBL] [Abstract][Full Text] [Related]
37. Publication ethics policies for medical journals. Pai SA Indian J Med Ethics; 2004; 1(3):93. PubMed ID: 16370089 [No Abstract] [Full Text] [Related]
38. CONSORT statement on the reporting standards in clinical trials. Recommendations are inappropriate for trial reports. Meade TW; Wald N; Collins R BMJ; 1997 Apr; 314(7087):1126; author reply 1127. PubMed ID: 9133902 [No Abstract] [Full Text] [Related]
39. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Dean ME; Coulter MK; Fisher P; Jobst KA; Walach H J Altern Complement Med; 2007; 13(1):19-23. PubMed ID: 17309373 [TBL] [Abstract][Full Text] [Related]
40. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Moher D; Schulz KF; Altman DG; J Am Podiatr Med Assoc; 2001 Sep; 91(8):437-42. PubMed ID: 11574648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]